Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease
Mark D. Eisner(Royal Victoria Infirmary), Paul D. Blanc(University of California, San Francisco), Edward H. Yelin(Pulmonary and Critical Care Associates), Patricia Katz(University of California, San Francisco), John R. Balmes, Laura Trupin(University of California, San Francisco)
Cited by 310
Related Papers
Lebrikizumab Treatment in Adults with Asthma
|New England Journal of Medicine|2011|1.5k
An Official American Thoracic Society Public Policy Statement: Novel Risk Factors and the Global Burden of Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2010|986
Pulmonary Dead-Space Fraction as a Risk Factor for Death in the Acute Respiratory Distress Syndrome
|New England Journal of Medicine|2002|898
Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury*
|Critical Care Medicine|2005|729
Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy
|Annals of Internal Medicine|2011|550